|
1
|
Singh A, Tetreault L, Kalsi-Ryan S, Nouri
A and Fehlings MG: Global prevalence and incidence of traumatic
spinal cord injury. Clin Epidemiol. 6:309–331. 2014.PubMed/NCBI
|
|
2
|
Evaniew N, Belley-Côté EP, Fallah N,
Noonan VK, Rivers CS and Dvorak MF: Methylprednisolone for the
treatment of patients with acute spinal cord injuries: A systematic
review and meta-analysis. J Neurotrauma. 33:468–481. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Choi DW and Rothman SM: The role of
glutamate neurotoxicity in hypoxic-ischemic neuronal death. J
Neurotrauma. 13:171–182. 1990.
|
|
4
|
Emery E, Aldana P, Bunge MB, Puckett W,
Srinivasan A, Keane RW, Bethea J and Levi AD: Apoptosis after
traumatic human spinal cord injury. J Neurosurg. 89:911–920. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hall ED and Braughler JM: Free radicals in
CNS injury. Res Publ Assoc Res Nerv Ment Dis. 71:81–105.
1993.PubMed/NCBI
|
|
6
|
Blight AR: Macrophages and inflammatory
damage in spinal cord injury. J Neurotrauma. 9:(Suppl 1). S83–S91.
1992.PubMed/NCBI
|
|
7
|
Lou J, Lenke LG, Ludwig FJ and O'Brien MF:
Apoptosis as a mechanism of neuronal cell death following acute
experimental spinal cord injury. Spinal Cord. 36:683–690. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yin X, Yin Y, Cao FL, Chen YF, Peng Y, Hou
WG, Sun SK and Luo ZJ: Tanshinone IIA attenuates the inflammatory
response and apoptosis after traumatic injury of the spinal cord in
adult rats. PLoS One. 7:e383812012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Silva NA, Sousa N, Reis RL and Salgado AJ:
From basics to clinical: A comprehensive review on spinal cord
injury. Prog Neurobiol. 114:25–57. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kwon BK, Tetzlaff W, Grauer JN, Beiner J
and Vaccaro AR: Pathophysiology and pharmacologic treatment of
acute spinal cord injury. Spine J. 4:451–464. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oh SK and Jeon SR: Current concept of stem
cell therapy for spinal cord injury: A review. Korean J
Neurotrauma. 12:40–46. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bracken MB, Shepard MJ, Collins WF Jr,
Holford TR, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon
JC, Marshall LF, et al: Methylprednisolone or naloxone treatment
after acute spinal cord injury: 1-year follow-up data. Results of
the second national acute spinal cord injury study. J Neurosurg.
76:23–31. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bracken MB, Shepard MJ, Collins WF,
Holford TR, Young W, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers
L, Maroon J, et al: A randomized, controlled trial of
methylprednisolone or naloxone in the treatment of acute
spinal-cord injury. Results of the second national acute spinal
cord injury study. N Engl J Med. 322:1405–1411. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bracken MB, Collins WF, Freeman DF,
Shepard MJ, Wagner FW, Silten RM, Hellenbrand KG, Ransohoff J, Hunt
WE, Perot PL Jr, et al: Efficacy of methylprednisolone in acute
spinal cord injury. JAMA. 251:45–52. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Harrop JS: Spinal cord injury: Debating
the efficacy of methylprednisolone. Neurosurgery. 61:(Suppl 1).
S30–S31. 2014. View Article : Google Scholar
|
|
16
|
Walters BC, Hadley MN, Hurlbert RJ, Aarabi
B, Dhall SS, Gelb DE, Harrigan MR, Rozelle CJ, Ryken TC, Theodore
N, et al: Guidelines for the management of acute cervical spine and
spinal cord injuries: 2013 update. Neurosurgery. 60:(Suppl 1).
S82–S91. 2013. View Article : Google Scholar
|
|
17
|
Liu T, Jin H, Sun QR, Xu JH and Hu HT: The
neuroprotective effects of tanshinone IIA on ß-amyloid-induced
toxicity in rat cortical neurons. Neuropharmacology. 59:595–604.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Z, Wang J, Huang E, Gao S, Li H, Lu J,
Tian K, Little PJ, Shen X, Xu S and Liu P: Tanshinone IIA
suppresses cholesterol accumulation in human macrophages: Role of
heme oxygenase-1. J Lipid Res. 55:201–213. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yin Y, Sun W, Li Z, Zhang B, Cui H, Deng
L, Xie P, Xiang J and Zou J: Effects of combining
methylprednisolone with rolipram on functional recovery in adult
rats following spinal cord injury. Neurochem Int. 62:903–912. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kaech S and Banker G: Culturing
hippocampal neurons. Nat Protoc. 1:2406–2415. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Boomkamp SD, McGrath MA, Houslay MD and
Barnett SC: Epac and the high affinity rolipram binding conformer
of PDE4 modulate neurite outgrowth and myelination using an in
vitro spinal cord injury model. Br J Pharmacol. 171:2385–2398.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Burnette WN: ‘Western blotting’:
Electrophoretic transfer of proteins from sodium dodecyl
sulfate-polyacrylamide gels to unmodified nitrocellulose and
radiographic detection with antibody and radioiodinated protein A.
Anal Biochem. 112:195–203. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Basso DM, Beattie MS and Bresnahan JC: A
sensitive and reliable locomotor rating scale for open field
testing in rats. J Neurotrauma. 12:1–21. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tang Q, Han R, Xiao H, Shen J, Luo Q and
Li J: Neuroprotective effects of tanshinone IIA and/or
tetramethylpyrazine in cerebral ischemic injury in vivo and in
vitro. Brain Res. 1488:81–91. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun S, Yin Y, Yin X, Cao F, Luo D, Zhang
T, Li Y and Ni L: Anti-nociceptive effects of Tanshinone IIA (TIIA)
in a rat model of complete Freund's adjuvant (CFA)-induced
inflammatory pain. Brain Res Bull. 88:581–588. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu J, Fan G, Chen S, Wu Y, Xu XM and Hsu
CY: Methylprednisolone inhibition of TNF-alpha expression and NF-kB
activation after spinal cord injury in rats. Brain Res Mol Brain
Res. 59:135–142. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
A randomized, controlled trial of
methylprednisolone or naloxone in the treatment of acute
spinal-cord injury. N Engl J Med. 323:1207–1209. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ito Y, Sugimoto Y, Tomioka M, Kai N and
Tanaka M: Does high dose methylprednisolone sodium succinate really
improve neurological status in patient with acute cervical cord
injury? A prospective study about neurological recovery and early
complications. Spine (Phila Pa 1976). 34:2121–2124. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Suberviola B, González-Castro A, Llorca J,
Ortiz-Melón F and Miñambres E: Early complications of high-dose
methylprednisolone in acute spinal cord injury patients. Injury.
39:748–752. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Matsumoto T, Tamaki T, Kawakami M, Yoshida
M, Ando M and Yamada H: Early complications of high-dose
methylprednisolone sodium succinate treatment in the follow-up of
acute cervical spinal cord injury. Spine (Phila Pa 1976).
26:426–430. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chikuda H, Yasunaga H, Takeshita K,
Horiguchi H, Kawaguchi H, Ohe K, Fushimi K and Tanaka S: Mortality
and morbidity after high-dose methylprednisolone treatment in
patients with acute cervical spinal cord injury: A
propensity-matched analysis using a nationwide administrative
database. Emerg Med J. 31:201–206. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu J, Ashwell KW and Waite P: Advances in
secondary spinal cord injury: Role of apoptosis. Spine (Phila Pa
1976). 25:1859–1866. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mautes AE, Weinzierl MR, Donovan F and
Noble LJ: Vascular events after spinal cord injury: Contribution to
secondary pathogenesis. Phys Ther. 80:673–687. 2000.PubMed/NCBI
|
|
34
|
Kroemer G, Galluzzi L and Brenner C:
Mitochondrial membrane permeabilization in cell death. Physiol Rev.
87:99–163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Korsmeyer SJ, Shutter JR, Veis DJ, Merry
DE and Oltvai ZN: Bcl-2/Bax: A rheostat that regulates an
anti-oxidant pathway and cell death. Semin Cancer Biol. 4:327–332.
1993.PubMed/NCBI
|
|
36
|
Thornberry NA: The caspase family of
cysteine proteases. Br Med Bull. 53:478–490. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Miller DK: The role of the Caspase family
of cysteine proteases in apoptosis. Semin Immunol. 9:35–49. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xia WJ, Yang M, Fok TF, Li K, Chan WY, Ng
PC, Ng HK, Chik KW, Wang CC, Gu GJ, et al: Partial neuroprotective
effect of pretreatment with tanshinone IIA on neonatal
hypoxia-ischemia brain damage. Pediatr Res. 58:784–790. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Meng XF, Zou XJ, Peng B, Shi J, Guan XM
and Zhang C: Inhibition of ethanol-induced toxicity by tanshinone
IIA in PC12 cells. Acta Pharmacol Sin. 27:659–664. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dong H, Mao S, Wei J, Liu B, Zhang Z,
Zhang Q and Yan M: Tanshinone IIA protects PC12 cells from
beta-amyloid(25–35)-induced apoptosis via PI3K/Akt signaling
pathway. Mol Biol Rep. 39:6495–6503. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lee JM, Yan P, Xiao Q, Chen S, Lee KY, Hsu
CY and Xu J: Methylprednisolone protects oligodendrocytes but not
neurons after spinal cord injury. J Neurosci. 28:3141–3149. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ege E, Ilhan A, Gurel A, Akyol O and Ozen
S: Erdosteine ameliorates neurological outcome and oxidative stress
due to ischemia/reperfusion injury in rabbit spinal cord. Eur J
Vasc Endovasc Surg. 28:379–386. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Topsakal C, Erol FS, Ozveren MF, Yilmaz N
and Ilhan N: Effects of methylprednisolone and dextromethorphan on
lipid peroxidation in an experimental model of spinal cord injury.
Neurosurg Rev. 25:258–266. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fu J, Huang H, Liu J, Pi R, Chen J and Liu
P: Tanshinone IIA protects cardiac myocytes against oxidative
stress-triggered damage and apoptosis. Eur J Pharmacol.
568:213–221. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sadeghi A, Ebrahimi Seyyed SS, Golestani A
and Meshkani R: Resveratrol Ameliorates Palmitate-Induced
inflammation in skeletal muscle cells by attenuating oxidative
stress and JNK/NF-KB pathway in a SIRT1-independent mechanism. J
Cell Biochem. Jan 6–2017.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen Y, Wu X, Yu S, Lin X, Wu J, Li L,
Zhao J and Zhao Y: Neuroprotection of tanshinone IIA against
cerebral ischemia/reperfusion injury through inhibition of
macrophage migration inhibitory factor in rats. PLoS One.
7:e401652012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chengke L, Weiwei L, Xiyang W, Ping W,
Xiaoyang P, Zhengquan X, Hao Z, Penghui Z and Wei P: Effect of
infliximab combined with methylprednisolone on expressions of
NF-κB, TRADD, and FADD in rat acute spinal cord injury. Spine
(Phila Pa 1976). 38:E861–E869. 2013. View Article : Google Scholar : PubMed/NCBI
|
